Browsing by Author Brunet i Serra, Mercè

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
25-Jul-2019A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatmentsArranz, María Jesús; González Rodríguez, Alexandre; Pérez Blanco, Josefina; Penadés Rubio, Rafael; Gutiérrez, Blanca; Ibáñez Lladó, Laura; Arias Sampériz, Bárbara; Brunet i Serra, Mercè; Cervilla, Jorge; Salazar, Juliana; Catalán, Rosa
3-Jul-2021Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantationMillán, Olga; Rovira, Jordi; Guirado, Lluis; Espinosa, Cristina; Budde, Klemens; Sommerer, Claudia; Piñeiro, Gaston J.; Diekmann, Fritz; Brunet i Serra, Mercè
2012Clinical pharmacokinetics of mycophenolic acid and its metabolites in solid organ transplant recipientColom Codina, Helena; Lloberas Blanch, Núria; Caldés, Ana; Andreu, Franc; Torras Ambròs, Joan; Oppenheimer Salinas, Federico; Sánchez-Plumed, Jaime; Gentil, Miguel A.; Kuypers, Dirk R.; Brunet i Serra, Mercè; Ekberg, Henrik; Grinyó Boira, Josep M.
22-Jan-2021Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patientsQuintairos Domenech, Luis; Colom Codina, Helena; Millán, Olga; Fortuna, Virginia; Espinosa, Cristina; Guirado, Lluís; Budde, Klemens; Sommerer, Claudia; Lizana, Ana; López Púa, Yolanda; Brunet i Serra, Mercè
9-Dec-2022Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant CyclophosphamideMarco, Daniel N.; Salas. Maria Queralt; Gutiérrez García, Gonzalo; Monge Escartín, Inés; Riu, Gisela; Carcelero, Esther; Roma, Joan Ramon; Llobet, Noemí; Arcarons, Jordi; Suárez Lledó, María; Martínez, Nuria; Pedraza, Alexandra; Domenech, Ariadna; Rosiñol, Laura; Fernández Avilés, Francesc; Urbano Ispizua, Álvaro; Rovira, Montserrat; Brunet i Serra, Mercè; Martínez, Carmen
1-Jan-1985Metodologia analítica en les intoxicacions agudesRodamilans Pérez, Miguel; Guevara Ortiz de Pinedo, A.; Marquès Alamo, J.; Brunet i Serra, Mercè; Pou Fernández, Jordi
Jan-2022miRNA-155-5p, miRNA-181a-5p, and miRNA-122-5p as prognostic biomarkers of clinical graft evolution in liver transplant patientsMarone Millà, Eva
24-Apr-2019Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients.Millán López, Olga; Ruiz, P.; Orts, Lara; Ferré Aparicio, Paula; Crespo, Gonzalo; Santana, Miguel; Fortuna, Virginia; Quintairos Domenech, Luis; Navasa, Miquel; Brunet i Serra, Mercè
8-Jul-2021Population pharmacokinetic-pharmacodynamic modeling in solid organ transplantation: Basis of personalized immunosuppressionQuintairos Domenech, Luis
29-Nov-2011Population Pharmacokinetics of Mycophenolic Acid (MPA) and its Metabolites (MPAG and AcMPAG) (Seminaris de Recerca 2011)Colom Codina, Helena; Lloberas Blanch, Núria; Caldés, Ana; Andreu, Franc; Oppenheimer Salinas, Federico; Sánchez-Plumed, Jaime; Gentil, Miguel A.; Kuypers, Dirk R.; Brunet i Serra, Mercè; Ekberg, Henrik; Grinyó Boira, Josep M.
24-Jun-2020The influence of CYP enzymes and ABCB1 on treatment outcomes in schizophrenia: association of CYP1A2 activity with adverse effectsCendrós, Marc; Arranz, María Jesús; Torra, Mercè; Penadés Rubio, Rafael; Gonzalez-Rodriguez A; Brunet i Serra, Mercè; Pérez Blanco, Josefina; Ibáñez Lladó, Laura; Serra, Àlex; Catalán, Rosa